GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93021C00012EMMES COMPANY, LLC, THE

Overview

Award facts

Net obligations
$176.56M
$176,560,287of $294.03M potential value
Outlays (paid to date)
$142.41M
$142.41M paid of $176.56M obligated$142,412,329
Period of performance
Mar 1, 2021 to Feb 28, 2027
Ends in 3 months
Modifications
22
Latest action Oct 28, 2026
Contract type
Definitive contract
PIID 75N93021C00012

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES (SDCC)

Dates and value

Award date
Signed on Mar 1, 2021
Potential end of performance
Feb 29, 2028
Current value
$176,560,287Base and exercised options
Potential value (if all options are exercised)
$294,026,311

Obligations by fiscal year of action

  • FY2026: $26,229,636
  • FY2025: $26,737,744
  • FY2024: $30,170,983
  • FY2023: $34,018,712
  • FY2022: $29,229,367
  • FY2021: $30,173,845

Total across 6 fiscal years: $176,560,287

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 28, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationROCKVILLE, MD
UEINBQCBJ6FXBU4
CAGE code3EX59
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyTHE EMMES COMPANY LLC

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Public health and social services emergency fund; National institute of allergy and infectious diseases (0885); Nih office of the director (0846); Nih royaltiesProgram activities075-0140, 075-0846, 075-0885, 075-3966Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-1785
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
2

Solicitation and notices

Solicitation ID
75N93019R00027
Solicitation date
Nov 22, 2020
Notices

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Statistical data and coordinating center (SDCC) for clinical research in infectious diseases
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Mar 1, 2021Base obligation at award: $20,905,668
Latest action
Oct 28, 2026 — Supplemental agreement (within scope)Modification P00022
Latest substantive action
Oct 28, 2026 — Supplemental agreement (within scope)Modification P00022
Actions by type
  • Base award1
  • Option exercised12
  • Supplemental agreement (within scope)8
  • Other administrative action2
23 actions recorded, Mar 1, 2021 to Oct 28, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
23

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2021/2024-0140-000
  • 075-2022/2022-0846-000
  • 075-2022/2022-0885-000
  • 075-2022/2024-3966-000
Show all 12 accounts
  • 075-2023/2023-0885-000
  • 075-2023/2025-3966-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
  • 075-2026/2026-0885-000
  • 075-X-0140-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • U: Emergency P.L. 116-260
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$28,563,022
COVID-19 supplemental outlays
$28,298,434